pharmatimesSeptember 08, 2017
Intercept has announced the winners of its 2017 Practice to Policy Health Awards Programme in Europe and Canada. In the UK funding was awarded to projects from three organisations:
The Practice to Policy awards programme was first launched in 2016 to support the development of innovative solutions which encourage high-standards of primary biliary cholangitis (PBC) patient care.
In its second year the programme invited applications focused on initiatives which empowered PBC patients, receiving 23 applications from 10 countries. Out of the diverse submissions received, 9 winning organisations were selected for funding by the programme’s panel of judges, chaired by Lisa Bright, President, International at Intercept. Judges included Intercept representatives, patient group leaders and PBC experts, including a representative from the European Association for the Study of the Liver (EASL).
Bright commented: "Through the Practice to Policy Programme, we’re committed to supporting locally based, innovative projects which further enhance support to people with PBC – be they projects with patients, community organisations, healthcare professionals or a combination. It’s great to see the level of enthusiasm for the programme again this year, where the real benefit will come from the broader project learnings – what worked, what didn’t and how can that accelerate adoption of innovation between countries."
Stewart Sharpe, Intercept's Regional Vice President, UK & Ireland, Nordics & Australasia, and General Manager UK & Ireland, added: "It is hugely encouraging to see that a third of the winning applicants selected for funding by the international panel are UK organizations. This clearly reflects the level of interest in the management of PBC within the UK, the high quality of the applications and the desire of the clinical and patient group community to improve outcomes for patients with PBC.’"
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: